Coarse particulate matter in air may harm hearts of asthma sufferers, UNC study findsMay 10, 2007CHAPEL HILL - Breathing air containing coarse particulate matter such as road or construction dust may cause heart problems for asthma sufferers and other vulnerable populations, according to a new study led by the University of North Carolina at Chapel Hill School of Public Health. The researchers found that in people with asthma, a small increase in coarse particulate matter in outdoor air raised bad cholesterol and increased the count of inflammation-linked white blood cells, among other changes. "This research was all done with study participants just being outside and breathing outdoor air," said Dr. Karin Yeatts, research assistant professor of epidemiology at the UNC School of Public Health, a member of the UNC Center for Environmental Medicine, Asthma and Lung Biology, and the study's principal investigator. "Our results indicate that susceptible people really need to pay attention to air pollution warnings and stay inside when the air pollution is bad. This is particularly the case for people with asthma." The study, published in the May 2007 issue of Environmental Health Perspectives, was a collaboration by researchers from the School of Public Health, the School of Medicine's Center for Environmental Medicine, Asthma and Lung Biology and the U.S. Environmental Protection Agency (EPA). The team found that when adult asthma sufferers were exposed to a one microgram per cubic meter increase in coarse particulate matter in ambient air their triglyceride levels increased by nearly five percent. Elevated levels of triglycerides have been shown to increase one's risk of coronary heart disease. The amount of eosinophils in study participants' blood also increased by 0.16 percent after exposure to the higher levels of coarse particulate matter. Eosinophils are a type of white blood cell created by the human body to fight infections, allergies and diseases like asthma among other things. Finally, the same increase in coarse particulate matter resulted in a three percent decrease in a measure of heart rate variability, the variation of the beat-to-beat intervals of the heart. A healthy heart has wide heart rate variability, while decreased variability can indicate stress or cardiac disease. Surprisingly, there was no relationship between coarse particulate matter and rescue medication use, asthma symptoms, lung function or airway inflammatory markers, Yeatts said. However, 10 of the 12 adult asthmatics in the study were taking anti-inflammatory controller medication for their disease, and nine of the 12 had mild disease. It is possible that anti-inflammatory treatment mitigated the effects in their airways, or that adults with asthma are less susceptible to the effects of coarse particulate matter. Study participants consisted of 12 adults between the ages of 21 and 50 with persistent asthma. All lived within a 30-mile radius of the study's particulate matter monitor, located on the EPA Human Studies Facility at the Carolina campus. Each study participant took part in nine clinic visits: five the first week, and four spaced randomly over the subsequent six to 11 weeks. Data collection took place between September 2003 and July 2004. During the study, outdoor air levels of coarse particulate matter ranged between zero to 14.6 micrograms per cubic meter and did not exceed safety levels set by the EPA of 150 micrograms per cubic meter. Other study authors include Lawrence Kupper, Alumni Distinguished Professor of biostatistics in the UNC School of Public Health; Dr. David Peden, director of the UNC Center for Environmental Medicine, Asthma and Lung Biology; Neil Alexis and Margaret Herbst, UNC Center for Environmental Medicine, Asthma and Lung Biology; Erik Svendsen, John Creason, James Scott, Lucas Neas, Robert Devlin and Ronald Williams of the EPA; and Dr. Wayne Cascio of Eastern Carolina University's Brody School of Medicine. University of North Carolina at Chapel Hill |
|||||||||||||||||||||
| Related Asthma Current Events and Asthma News Articles Exposures to metals and diesel emissions in air linked to respiratory symptoms in children Exposure shortly after birth to ambient metals from residential heating oil combustion and particles from diesel emissions are associated with respiratory symptoms in young inner city children. Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later New research presents strong evidence that the "synergistic" effect of early-life exposure to both outdoor traffic-related pollution and indoor endotoxin causes more harm to developing lungs than one or the other exposure alone. Johns Hopkins researchers track down protein responsible for chronic rhinosinusitis with polyps A protein known to stimulate blood vessel growth has now been found to be responsible for the cell overgrowth in the development of polyps that characterize one of the most severe forms of sinusitis, a study by Johns Hopkins researchers suggests. Ancestry attracts, but love is blind People preferentially marry those with similar ancestry, but their decisions are not necessarily based on hair, eye or skin colour. Common plastics chemicals linked to ADHD symptoms Phthalates are important components of many consumer products, including toys, cleaning materials, plastics, and personal care items. Asthma a significant risk factor for complications in children with H1N1 A new study on pediatric H1N1 influenza admissions has found that asthma is a significant risk factor for severe disease in children with pandemic H1N1 compared with the seasonal flu. Mother's Depression a Risk Factor in Childhood Asthma Symptoms, Study Suggests Asthma symptoms can worsen in children with depressed mothers, according to research from Johns Hopkins Children's Center published online in the Journal of Pediatric Psychology. Sweet -- sugared polymer a new weapon against allergies and asthma Scientists at Johns Hopkins and their colleagues have developed sugar-coated polymer strands that selectively kill off cells involved in triggering aggressive allergy and asthma attacks. Pivotal study for PSD502 -- the first potential treatment for premature ejaculation At the annual meeting of the Sexual Medicine Society of North America (SMSNA), Inc. in San Diego, Sciele Pharma, Inc., a Shionogi Company and Plethora Solutions Limited, a wholly owned subsidiary of Plethora Solutions Holdings PLC ("Plethora" - AIM:PLE)., today presented data from its second positive pivotal study of PSD502 for the treatment of premature ejaculation (PE). Aileron collaborates study in Nature: Stapled peptides inhibit Notch1 transcription factor This research validates the potential for Stapled Peptides to modulate key intracellular biological targets, such as transcription factors, that have not been addressable with current small molecule or biologic drug modalities. More Asthma Current Events and Asthma News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||